NO902933D0 - Fremgangsmaate for fremstilling av 2-(aminoaryl)indoler ogindoliner samt anvendelse som medikamenter. - Google Patents

Fremgangsmaate for fremstilling av 2-(aminoaryl)indoler ogindoliner samt anvendelse som medikamenter.

Info

Publication number
NO902933D0
NO902933D0 NO902933A NO902933A NO902933D0 NO 902933 D0 NO902933 D0 NO 902933D0 NO 902933 A NO902933 A NO 902933A NO 902933 A NO902933 A NO 902933A NO 902933 D0 NO902933 D0 NO 902933D0
Authority
NO
Norway
Prior art keywords
indolines
aminoaryl
indoles
medicines
procedure
Prior art date
Application number
NO902933A
Other languages
English (en)
Other versions
NO902933L (no
Inventor
John Joseph Tegeler
Eileen Mary Gardenhire
Grover Cleveland Helsley
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of NO902933D0 publication Critical patent/NO902933D0/no
Publication of NO902933L publication Critical patent/NO902933L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO90902933A 1989-07-03 1990-07-02 Fremgangsmaate for fremstilling av 2-(aminoaryl)indoler ogindoliner samt anvendelse som medikamenter. NO902933L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/375,550 US5166170A (en) 1989-07-03 1989-07-03 2-(aminoaryl) indoles and indolines as topical antiinflammatory agents for the treatment of skin disorders

Publications (2)

Publication Number Publication Date
NO902933D0 true NO902933D0 (no) 1990-07-02
NO902933L NO902933L (no) 1991-01-04

Family

ID=23481318

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90902933A NO902933L (no) 1989-07-03 1990-07-02 Fremgangsmaate for fremstilling av 2-(aminoaryl)indoler ogindoliner samt anvendelse som medikamenter.

Country Status (13)

Country Link
US (1) US5166170A (no)
EP (1) EP0406734A3 (no)
JP (1) JPH0344370A (no)
KR (1) KR910002795A (no)
AU (1) AU5801990A (no)
CA (1) CA2020298A1 (no)
FI (1) FI903298A0 (no)
HU (1) HUT54643A (no)
IE (1) IE902402A1 (no)
IL (1) IL94951A0 (no)
NO (1) NO902933L (no)
PT (1) PT94573A (no)
ZA (1) ZA905148B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
US6630496B1 (en) 1996-08-26 2003-10-07 Genetics Institute Llc Inhibitors of phospholipase enzymes
US6916841B2 (en) * 1998-02-25 2005-07-12 Genetics Institute, Llc Inhibitors of phospholipase enzymes
US6828344B1 (en) 1998-02-25 2004-12-07 Genetics Institute, Llc Inhibitors of phospholipase enzymes
US6500853B1 (en) 1998-02-28 2002-12-31 Genetics Institute, Llc Inhibitors of phospholipase enzymes
FR2779723B1 (fr) * 1998-06-12 2000-07-13 Cird Galderma Composes biaryles heterocycliques aromatiques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
US6635771B2 (en) 2001-12-03 2003-10-21 Wyeth N-benzhydryl indole compounds
US7713964B2 (en) * 2001-12-03 2010-05-11 Wyeth Llc Methods for treating asthmatic conditions
US7605156B2 (en) * 2001-12-03 2009-10-20 Wyeth Methods for the use of inhibitors of cytosolic phospholipase A2
US6797708B2 (en) * 2001-12-03 2004-09-28 Wyeth Inhibitors of cytosolic phospholipase A2
US7101875B2 (en) * 2001-12-03 2006-09-05 Wyeth Methods for treating arthritic disorders
US6984735B2 (en) * 2001-12-03 2006-01-10 Wyeth Process for making an aldehyde
RU2004126671A (ru) * 2002-02-06 2005-04-10 Вертекс Фармасьютикалз Инкорпорейтед (Us) Гетероарилсоединения, полезные в качестве ингибиторов gsk-3
JP4500689B2 (ja) 2002-12-26 2010-07-14 エーザイ・アール・アンド・ディー・マネジメント株式会社 選択的エストロゲン受容体モジュレーター
US8076352B2 (en) 2004-03-15 2011-12-13 Ptc Therapeutics, Inc. Administration of carboline derivatives useful in the treatment of cancer and other diseases
US8076353B2 (en) 2004-03-15 2011-12-13 Ptc Therapeutics, Inc. Inhibition of VEGF translation
US7767689B2 (en) 2004-03-15 2010-08-03 Ptc Therapeutics, Inc. Carboline derivatives useful in the treatment of cancer
SG151267A1 (en) 2004-03-15 2009-04-30 Ptc Therapeutics Inc Carboline derivatives useful in the inhibition of angiogenesis
US7772271B2 (en) 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7868037B2 (en) 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US8013006B2 (en) 2004-07-14 2011-09-06 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
JP2008507518A (ja) 2004-07-22 2008-03-13 ピーティーシー セラピューティクス，インコーポレーテッド Ｃ型肝炎を治療するためのチエノピリジン
TW200718687A (en) * 2005-05-27 2007-05-16 Wyeth Corp Inhibitors of cytosolic phospholipase A2
AR072297A1 (es) 2008-06-27 2010-08-18 Novartis Ag Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.
DK3122426T3 (da) 2014-03-28 2023-04-03 Univ Duke Behandling af brystcancer ved anvendelse af selektive østrogenreceptormodulatorer
US9421264B2 (en) 2014-03-28 2016-08-23 Duke University Method of treating cancer using selective estrogen receptor modulators

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3259622A (en) * 1962-09-07 1966-07-05 Merck & Co Inc 1-benzyl-3-indolyl-alpha-haloalkyl and alkylidenyl acetic acids
US3642778A (en) * 1969-10-22 1972-02-15 Robins Co Inc A H Benzimidazo(1 2-d)(1 4)benzodiazepin-6(5h)-ones
US3642779A (en) * 1969-10-22 1972-02-15 Robins Co Inc A H Indolo(1 2-d)(1 4)benzodiazepin-6-ones
US3941806A (en) * 1970-04-14 1976-03-02 A. H. Robins Company 7-(α-Acetylbenzyl)indoline
US3732236A (en) * 1971-04-12 1973-05-08 Mead Johnson & Co 2-phenyl-indoline amidines
FR2275461A1 (fr) * 1974-06-18 1976-01-16 Labaz Nouveaux stabilisants des polymeres et copolymeres du chlorure de vinyle
US4448784A (en) * 1982-04-12 1984-05-15 Hoechst-Roussel Pharmaceuticals, Inc. 1-(Aminoalkylphenyl and aminoalkylbenzyl)-indoles and indolines and analgesic method of use thereof
LU85544A1 (fr) * 1984-09-19 1986-04-03 Cird Derives heterocycliques aromatiques,leur procede de preparation et leur application dans les domaines therapeutique et cosmetique
JPS6253962A (ja) * 1985-08-31 1987-03-09 Teikoku Hormone Mfg Co Ltd ２−フエニルインド−ル誘導体
EP0226508A1 (fr) * 1985-12-02 1987-06-24 Sanofi Dérivés de l'indolo(3,2-c)quinoléine, leur procédé de préparation et leur activité antitumorale
FR2590899A1 (fr) * 1985-12-02 1987-06-05 Sanofi Sa Chloro-6 11-h indolo 3,2-c quinoleines un procede de preparation et leur application en tant qu'intermediaires de synthese
FR2614618B1 (fr) * 1987-04-30 1989-07-07 Cird Derives heterocycliques polycycliques, leur procede de preparation et leur utilisation en medecine humaine et veterinaire

Also Published As

Publication number Publication date
US5166170A (en) 1992-11-24
CA2020298A1 (en) 1991-01-04
IL94951A0 (en) 1991-06-10
EP0406734A2 (en) 1991-01-09
PT94573A (pt) 1991-03-20
HUT54643A (en) 1991-03-28
IE902402A1 (en) 1991-06-19
AU5801990A (en) 1991-01-03
ZA905148B (en) 1991-04-24
JPH0344370A (ja) 1991-02-26
FI903298A0 (fi) 1990-06-29
NO902933L (no) 1991-01-04
HU904059D0 (en) 1990-12-28
KR910002795A (ko) 1991-02-26
EP0406734A3 (en) 1991-12-27

Similar Documents

Publication Publication Date Title
NO902933L (no) Fremgangsmaate for fremstilling av 2-(aminoaryl)indoler ogindoliner samt anvendelse som medikamenter.
NO903925D0 (no) Fremgangsmaate for fremstilling av 3-(1-substituert-4-piperazinyl)-1h-indazoler samt anvendelse som legemidler.
NO904987D0 (no) Fremgangsmaate for fremstilling av indolderivater.
NO870075L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater.
NO893076D0 (no) Fremgangsmaate for fremstilling av aminomethyloxooxa-zolidinylarylbenzenderivater.
NO871790D0 (no) Fremgangsmaate for fremstilling av et oralt farmasoeytisk preparat.
NO905255L (no) Fremgangsmaate for fremstilling av heterocyklisk substituerte acylaminotiazoler.
NO895083L (no) Varmestabilisert sukralosepreparat, samt fremgangsmaate for fremstilling av et slikt.
NO873091D0 (no) Fremgangsmaate for fremstilling av nye benzimidazolderivater.
NO891951D0 (no) Fremgangsmaate for fremstilling av nye hydroksamat-derivater.
NO892936D0 (no) Fremgangsmaate for fremstilling av furanderivater.
NO890969L (no) Fremgangsmaate for fremstilling av isoindolinderivater.
NO903431L (no) Fremgangsmaate for fremstilling av kromanderivater.
NO901813D0 (no) Fremgangsmaate for fremstilling av nye tieno-triazolo-diazepin-derivater.
NO872158L (no) Fremgangsmaate ved fremstilling av nye aromatiske naftylderivater.
NO900074L (no) Fremgangsmaate for fremstilling av nye tetralinderivater.
NO891588L (no) Fremgangsmaate for fremstilling av fosfonoalkylpurinderivater.
NO901690D0 (no) Fremgangsmaate til fremstilling av substituerte azetidinylisotiazolpyridon-derivater.
NO890455D0 (no) Fremgangsmaate for fremstilling av 5-substituerte ornithin-derivater.
NO892977D0 (no) Fremgangsmaate for fremstilling av nye s-adenosylmethionin-derivater.
NO905327L (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbamoylderivater.
NO891381D0 (no) Fremgangsmaate for fremstilling av nye fluorfosfonatnukleotidderivater.
NO891574D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.
NO872393L (no) Fremgangsmaate for fremstilling av nye aralkylimidazolderivater.
NO901422D0 (no) Fremgangsmaate for fremstilling av alfa-glucosidase-inhibitorer.